195 related articles for article (PubMed ID: 9048847)
1. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Feb; 46(RR-5):13-21. PubMed ID: 9048847
[TBL] [Abstract][Full Text] [Related]
2. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
[TBL] [Abstract][Full Text] [Related]
3. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 2000 Jun; 49(RR-7):1-10. PubMed ID: 10902834
[TBL] [Abstract][Full Text] [Related]
4. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Cohn AC; MacNeil JR; Clark TA; Ortega-Sanchez IR; Briere EZ; Meissner HC; Baker CJ; Messonnier NE;
MMWR Recomm Rep; 2013 Mar; 62(RR-2):1-28. PubMed ID: 23515099
[TBL] [Abstract][Full Text] [Related]
5. Serogroup C meningococcal outbreaks in the United States. An emerging threat.
Jackson LA; Schuchat A; Reeves MW; Wenger JD
JAMA; 1995 Feb; 273(5):383-9. PubMed ID: 7823383
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 2000 Jun; 49(RR-7):13-20. PubMed ID: 10902835
[TBL] [Abstract][Full Text] [Related]
7. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of meningococcal vaccine and barriers to vaccination.
Rosenstein N; Levine O; Taylor JP; Evans D; Plikaytis BD; Wenger JD; Perkins BA
JAMA; 1998 Feb; 279(6):435-9. PubMed ID: 9466635
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations.
Baker CJ
J Adolesc Health; 2016 Aug; 59(2 Suppl):S29-37. PubMed ID: 27449147
[TBL] [Abstract][Full Text] [Related]
10. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.
Atkinson B; Gandhi A; Balmer P
Pharmacotherapy; 2016 Aug; 36(8):880-92. PubMed ID: 27332671
[TBL] [Abstract][Full Text] [Related]
11. Serogroup B meningococcal disease: new outbreaks, new strategies.
Wenger JD
JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326
[No Abstract] [Full Text] [Related]
12. Prevention of meningococcal infections in the first 2 years of life.
Woods CR
Pediatr Ann; 2013 Aug; 42(8):164-71. PubMed ID: 23910030
[TBL] [Abstract][Full Text] [Related]
13. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.
Jackson LA; Alexander ER; DeBolt CA; Swenson PD; Boase J; McDowell MG; Reeves MW; Wenger JD
Pediatr Infect Dis J; 1996 Nov; 15(11):992-8. PubMed ID: 8933547
[TBL] [Abstract][Full Text] [Related]
15. Evolving meningococcal immunization strategies.
Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
[TBL] [Abstract][Full Text] [Related]
16. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
[No Abstract] [Full Text] [Related]
17. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Bilukha OO; Rosenstein N;
MMWR Recomm Rep; 2005 May; 54(RR-7):1-21. PubMed ID: 15917737
[TBL] [Abstract][Full Text] [Related]
18. Vaccination strategies for the prevention of meningococcal disease.
Vuocolo S; Balmer P; Gruber WC; Jansen KU; Anderson AS; Perez JL; York LJ
Hum Vaccin Immunother; 2018 May; 14(5):1203-1215. PubMed ID: 29543535
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal disease.
Rosenstein NE; Perkins BA; Stephens DS; Popovic T; Hughes JM
N Engl J Med; 2001 May; 344(18):1378-88. PubMed ID: 11333996
[No Abstract] [Full Text] [Related]
20. Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease.
Watson PS; Turner DP
Vaccine; 2016 Feb; 34(7):875-80. PubMed ID: 26686570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
